IRIS
CITRARO, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.457
EU - Europa 1.436
AS - Asia 1.050
SA - Sud America 117
OC - Oceania 27
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 5.119
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.294
SG - Singapore 664
IT - Italia 624
DE - Germania 262
CN - Cina 159
CA - Canada 145
FI - Finlandia 144
GB - Regno Unito 122
SE - Svezia 105
BR - Brasile 91
IN - India 59
HK - Hong Kong 37
NL - Olanda 31
AU - Australia 26
TR - Turchia 21
ES - Italia 17
JP - Giappone 17
RU - Federazione Russa 16
UA - Ucraina 15
FR - Francia 14
IL - Israele 12
CZ - Repubblica Ceca 11
ID - Indonesia 11
RO - Romania 11
GR - Grecia 10
IR - Iran 10
MX - Messico 10
PL - Polonia 10
BD - Bangladesh 9
ZA - Sudafrica 9
CH - Svizzera 8
MT - Malta 7
PK - Pakistan 7
CO - Colombia 6
VN - Vietnam 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AR - Argentina 5
AT - Austria 5
EE - Estonia 5
EG - Egitto 5
PT - Portogallo 5
SA - Arabia Saudita 5
IQ - Iraq 4
KR - Corea 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AF - Afghanistan, Repubblica islamica di 3
BG - Bulgaria 3
CL - Cile 3
EU - Europa 3
HR - Croazia 3
PH - Filippine 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
EC - Ecuador 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
IE - Irlanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TL - Timor Orientale 1
Totale 5.119
Salva come PNG Salva come JPEG
Città #
Chandler 430
Singapore 357
Munich 230
Santa Clara 169
Milan 146
Princeton 128
Lawrence 127
Catanzaro 116
Ottawa 99
London 85
Wilmington 75
Chicago 70
Turku 68
Helsinki 67
Ashburn 66
Boardman 44
Des Moines 44
Hong Kong 36
Redwood City 31
New York 24
Los Angeles 23
Brooklyn 20
Shanghai 17
Guangzhou 16
Palermo 15
Rome 15
Norwalk 14
Florence 13
Melbourne 13
San Nicola Manfredi 13
Beijing 12
Shenzhen 12
The Dalles 12
Tokyo 12
Montreal 11
Olomouc 11
São Paulo 11
Istanbul 10
Toronto 9
Amsterdam 8
Bari 8
Council Bluffs 8
Messina 8
Naples 8
Padova 8
Phoenix 8
Pune 8
Warsaw 8
West Jordan 8
Atlanta 7
Aversa 7
Columbus 7
Curinga 7
Johannesburg 7
Prato 7
Assago 6
Boston 6
Chennai 6
Cosenza 6
Falls Church 6
Houston 6
Madrid 6
San Francisco 6
Tel Aviv 6
Teresina 6
Augusta 5
Casalnuovo di Napoli 5
Charlotte 5
Collegeville 5
Dallas 5
Fayetteville 5
Jyväskylä 5
Montague 5
Nuremberg 5
Reading 5
Redmond 5
Rende 5
Roccella Ionica 5
Washington 5
Ann Arbor 4
Beauharnois 4
Brisbane 4
Clearwater 4
Giza 4
Newark 4
Riyadh 4
Stockholm 4
Tashkent 4
Tehran 4
Vancouver 4
Viagrande 4
Vienna 4
Zhengzhou 4
Ahmedabad 3
Ballymena 3
Barcelona 3
Bengaluru 3
Bisignano 3
Buffalo 3
Caserta 3
Totale 3.000
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 210
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 114
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 108
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 80
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 76
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 73
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 59
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 58
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 58
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 52
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 52
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 52
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 52
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 51
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 51
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 51
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 51
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 51
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 49
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 49
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 49
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 48
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 48
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 47
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 46
Pharmacokinetic considerations about antiseizure medications in the elderly 46
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 46
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 45
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 45
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 44
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 44
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 44
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 44
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 44
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 44
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 44
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 44
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 43
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 43
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 43
Microbiota-gut brain axis involvement in neuropsychiatric disorders 42
Epidemiology and outcomes of status epilepticus 42
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 41
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 40
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 40
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  39
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 39
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 39
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. 38
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 38
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 38
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 38
Immediate and controlled-release pregabalin for the treatment of epilepsy 38
Pharmacovigilance in pharmaceutical companies: An overview 37
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 37
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 37
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 37
mTOR inhibition modulates epileptogenesis, seizures and depressive-like behavior in a genetic model of absence seizures and mild depression comorbidity: a role for inflammatory responses 36
Biomimetic Sonar for Electrical Activation of the Auditory Pathway 36
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 36
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 35
The potential role of cannabinoids in epilepsy treatment. 35
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 34
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 34
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 34
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 34
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 33
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 33
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 33
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 33
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 33
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 32
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 32
Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis 32
Can we ‘seize’ the gut microbiota to treat epilepsy? 32
Pharmacology of epileptogenesis and related comorbidities in the WAG/Rij rat model of genetic absence epilepsy 31
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 31
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 31
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40 31
Colchicine in Managing Skin Conditions: A Systematic Review 31
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 30
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 30
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 30
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 30
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 29
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 29
Antidepressants drugs for seizures and epilepsy: Where do we stand? 28
Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats 28
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 28
The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy 28
The sphingosine 1-phosphate signaling pathway in epilepsy: A possible role for the immunomodulator drug fingolimod in epilepsy treatment 28
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 28
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 27
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 27
When Nutraceuticals Reinforce Drugs Side Effects: A Case Report 27
Solution-phase parallel synthesis and evaluation of anticonvulsant activity of N-substituted-3,4-dihydroisoquinoline-2(1H)-carboxamides 27
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 27
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 27
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 26
Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy 26
Totale 4.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 14 2 20 30 22 145 42 9 38 11 15 5
2021/2022431 3 6 9 91 21 14 6 83 79 50 57 12
2022/20231.224 261 101 41 102 119 98 14 79 191 86 91 41
2023/2024729 120 89 63 59 54 120 31 46 11 47 29 60
2024/20252.139 261 71 104 88 142 267 162 93 236 69 265 381
2025/2026276 276 0 0 0 0 0 0 0 0 0 0 0
Totale 5.372